
Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin